Literature DB >> 17616028

Castleman disease presenting with jaundice: a case with the multicentric hyaline vascular variant.

Jun Bean Park1, Jin Hyeok Hwang, Haeryoung Kim, Hyung Sim Choe, Yu Kyeong Kim, Hong Bin Kim, Soo-Mee Bang.   

Abstract

Castleman disease (CD) is a rare lymphoproliferative disorder of unknown etiology with different clinical manifestations. A previous healthy 50 year-old man was hospitalized for right upper quadrant (RUQ) abdominal pain. He had jaundice and a 1 cm-sized lymph node in the right supraclavicular area. Pancreas and biliary computed tomography (CT) showed masses at the right renal hilum and peripancreatic areas. Positron emission tomography (PET) showed widespread systemic lymphadenopathy. Excisional biopsy of the right supraclavicular node revealed a hyaline vascular variant of CD. Corticosteroid therapy was started and the extent of disease decreased. We here report a case of multicentric CD, the hyaline vascular variant, presenting with jaundice, diagnosed by excisional biopsy and successfully treated with corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616028      PMCID: PMC2687612          DOI: 10.3904/kjim.2007.22.2.113

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  12 in total

1.  Castleman's disease causing obstructive jaundice.

Authors:  Rene Przkora; Christiane Bruns; Carl Zülke; Jürgen Heinkelein; Petra Rümmele; Andreas Schalhorn; Karl Walter Jauch
Journal:  J Hepatol       Date:  2003-04       Impact factor: 25.083

2.  FDG positron emission tomographic imaging of thoracic Castleman's disease.

Authors:  Madhusudhan P Reddy; Michael M Graham
Journal:  Clin Nucl Med       Date:  2003-04       Impact factor: 7.794

Review 3.  The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care.

Authors:  Corey Casper
Journal:  Br J Haematol       Date:  2005-04       Impact factor: 6.998

4.  Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.

Authors:  K Yoshizaki; T Matsuda; N Nishimoto; T Kuritani; L Taeho; K Aozasa; T Nakahata; H Kawai; H Tagoh; T Komori
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

Review 5.  Interleukin-6 family of cytokines and gp130.

Authors:  T Kishimoto; S Akira; M Narazaki; T Taga
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

6.  Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection.

Authors:  David M Menke; Amy Chadbum; Ethel Cesarman; Eric Green; James Berenson; Jonathan Said; Markus Tiemann; Reza Parwaresch; Stephan D Thome
Journal:  Am J Clin Pathol       Date:  2002-02       Impact factor: 2.493

7.  Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease.

Authors:  H Katano; Y Sato; T Kurata; S Mori; T Sata
Journal:  Virology       Date:  2000-04-10       Impact factor: 3.616

8.  The clinical behavior of localized and multicentric Castleman disease.

Authors:  J Herrada; F Cabanillas; L Rice; J Manning; W Pugh
Journal:  Ann Intern Med       Date:  1998-04-15       Impact factor: 25.391

9.  Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.

Authors:  Corey Casper; W Garrett Nichols; Meei-Li Huang; Lawrence Corey; Anna Wald
Journal:  Blood       Date:  2003-11-13       Impact factor: 22.113

10.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

View more
  10 in total

Review 1.  Castleman's disease: from basic mechanisms to molecular therapeutics.

Authors:  Hazem E El-Osta; Razelle Kurzrock
Journal:  Oncologist       Date:  2011-03-25

2.  Surgical management of isolated retroperitoneal Castleman's disease: A case report.

Authors:  Jun Xu; B O Zhou; Hua-Li Cao; B O Wang; Sheng Yan; Shu-Sen Zheng
Journal:  Oncol Lett       Date:  2016-02-02       Impact factor: 2.967

3.  Hyaline vascular castleman disease involving renal parenchyma and a lymph node: a case report.

Authors:  Ji Hyun Kwon; Soo Kee Min; Mi Kyung Shin; Yong Seong Lee; Young-Goo Lee; Young Hyeh Ko
Journal:  Korean J Pathol       Date:  2012-02-23

4.  A rare case of hyaline-type Castleman disease in the liver.

Authors:  Hisaaki Miyoshi; Shima Mimura; Takako Nomura; Joji Tani; Asahiro Morishita; Hideki Kobara; Hirohito Mori; Hirohito Yoneyama; Akihiro Deguchi; Takashi Himoto; Naoki Yamamoto; Keiichi Okano; Yasuyuki Suzuki; Tsutomu Masaki
Journal:  World J Hepatol       Date:  2013-07-27

5.  Localized retroperitoneal Castleman's disease: a case report and review of the literature.

Authors:  Rodrigo Aguilar-Rodriguez; Sorin-Lucian Milea; Ilhan Demirci; Susanne Herold; Michael Flasshove; Bernd Klosterhalfen; Horst Kinkel; Hermann Janßen
Journal:  J Med Case Rep       Date:  2014-03-10

6.  Castleman disease versus lymphoma in neck lymph nodes: a comparative study using contrast-enhanced CT.

Authors:  Jie Li; Jia Wang; Zhitao Yang; Hexiang Wang; Junyi Che; Wenjian Xu
Journal:  Cancer Imaging       Date:  2018-08-16       Impact factor: 3.909

7.  Case report: Castleman's disease involving the renal sinus resembling renal cell carcinoma.

Authors:  Enlong Zhang; Yuan Li; Ning Lang
Journal:  Front Surg       Date:  2022-09-05

8.  Castleman's disease of the renal sinus presenting as a urothelial malignancy: a brief case report.

Authors:  Se Min Jang; Hulin Han; Ki-Seok Jang; Young Jin Jun; Tchun Yong Lee; Seung Sam Paik
Journal:  Korean J Pathol       Date:  2012-10-25

9.  Castleman's Disease of the Porta Hepatis.

Authors:  Bita Geramizadeh; Mohammad Reza Fattahi; Kamran Bagheri Lankarani
Journal:  Middle East J Dig Dis       Date:  2012-07

10.  An Autopsy Case of Multicentric Castleman Disease Presenting with Severe Jaundice.

Authors:  Yuichi Yamazaki; Yuka Yoshida; Megumi Shimizu; Takeshi Kobayashi; Hiroki Tojima; Ken Sato; Satoru Kakizaki; Hiroshi Handa; Hideaki Yokoo; Toshio Uraoka
Journal:  Intern Med       Date:  2021-06-05       Impact factor: 1.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.